Bihua Chen is the Founder of Cormorant Asset Management, LP, an investment firm focused on innovative biotech, medtech and life science companies with over $3 billion in assets under management. Prior to founding Cormorant, Ms. Chen managed an account focused on the health care sector as a sub-adviser to a large, multi-strategy hedge fund based in New York. Ms. Chen holds a BS in genetics and genetic engineering from Fudan University, an MS in molecular biology from the Graduate School of Biomedical Science at Cornell Medical College and an MBA from the Wharton School of Business.